CH560207A5 - - Google Patents

Info

Publication number
CH560207A5
CH560207A5 CH135272A CH135272A CH560207A5 CH 560207 A5 CH560207 A5 CH 560207A5 CH 135272 A CH135272 A CH 135272A CH 135272 A CH135272 A CH 135272A CH 560207 A5 CH560207 A5 CH 560207A5
Authority
CH
Switzerland
Application number
CH135272A
Original Assignee
Frosst & Co Charles E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frosst & Co Charles E filed Critical Frosst & Co Charles E
Publication of CH560207A5 publication Critical patent/CH560207A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
CH135272A 1968-05-22 1969-05-21 CH560207A5 (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73133368A 1968-05-22 1968-05-22
US81809069A 1969-04-21 1969-04-21
US17914571A 1971-09-09 1971-09-09
US17914771A 1971-09-09 1971-09-09

Publications (1)

Publication Number Publication Date
CH560207A5 true CH560207A5 (xx) 1975-03-27

Family

ID=27497322

Family Applications (1)

Application Number Title Priority Date Filing Date
CH135272A CH560207A5 (xx) 1968-05-22 1969-05-21

Country Status (7)

Country Link
AT (1) AT289789B (xx)
BE (1) BE733390A (xx)
CH (1) CH560207A5 (xx)
CY (1) CY762A (xx)
DE (1) DE1925956C3 (xx)
FR (1) FR2009110A1 (xx)
GB (1) GB1253709A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
EP0105996A1 (en) * 1982-10-15 1984-04-25 Merck & Co. Inc. Ophthalmic compositions for treating elevated intraocular pressure
EP0117089B1 (en) * 1983-02-03 1988-12-14 The Regents Of The University Of California Beta-adrenergic antagonist compounds and derivatives of beta-adrenergic antagonists
US4687873A (en) * 1983-02-03 1987-08-18 The Regents Of The University Of California Derivatives of β-adrenergic antagonists
US5482916A (en) * 1989-08-22 1996-01-09 Tosoh Corporation Thiadiazole derivatives and herbicide compositions containing same
EP0414511A1 (en) * 1989-08-22 1991-02-27 Tosoh Corporation Thiadiazole derivatives and herbicide compositions containing the same
AU660735B2 (en) * 1991-10-11 1995-07-06 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
US5821371A (en) * 1994-10-24 1998-10-13 Eli Lilly And Comany Heterocyclic compounds and their preparation and use
EP2050441A1 (en) 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
US3419573A (en) * 1965-10-15 1968-12-31 Merck & Co Inc 3-chloro-4-oxy-1,2,5-thiadiazoles, and a process for preparing same

Also Published As

Publication number Publication date
DE1925956A1 (de) 1969-11-27
FR2009110A1 (xx) 1970-01-30
DE1925956C3 (de) 1980-07-31
DE1925956B2 (de) 1979-11-22
GB1253709A (en) 1971-11-17
AT289789B (de) 1971-05-10
CY762A (en) 1974-11-01
BE733390A (xx) 1969-11-21

Similar Documents

Publication Publication Date Title
AU1946070A (xx)
BE726762A (xx)
AU428130B2 (xx)
AU2374870A (xx)
AU5184069A (xx)
FR2009110A1 (xx)
AU429879B2 (xx)
AU416157B2 (xx)
AU2581067A (xx)
AU4811568A (xx)
AU421558B1 (xx)
AR203075Q (xx)
AU3224368A (xx)
AU4744468A (xx)
AU2580267A (xx)
AU3789668A (xx)
BE726714A (xx)
BE726352A (xx)
AU3083868A (xx)
AU2889368A (xx)
BE727934A (xx)
BE709496A (xx)
AU4224469A (xx)
BE727718A (xx)
BE727565A (xx)

Legal Events

Date Code Title Description
PL Patent ceased